Cynthia C. Harrington

Quality of life, psychological distress, and prognostic perceptions in patients with multiple myeloma

K. Anderson, N. Munshi, J. Laubach, 2022, Cancer.

Quality of life, psychological distress, and prognostic perceptions in caregivers of patients with multiple myeloma

N. Munshi, J. Laubach, P. Richardson, 2022, Blood advances.

A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant‐ineligible multiple myeloma

L. Trippa, N. Munshi, J. Laubach, 2018, British journal of haematology.

A Phase II Study of Elotuzumab in Combination with Pomalidomide, Bortezomib, and Dexamethasone in Relapsed and Refractory Multiple Myeloma

J. Lohr, J. Laubach, P. Richardson, 2019, Blood.

A phase II study of elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma.

J. Lohr, J. Laubach, P. Richardson, 2018 .

Quality of Life, Psychological Distress, and Prognostic Awareness in Caregivers of Patients with Multiple Myeloma

N. Munshi, J. Laubach, P. Richardson, 2021, Blood.